1832 Asset Management’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $194M | Sell |
4,556,876
-2,695,870
| -37% | -$146M | 0.1% | 110 |
|
|
2026
Q1 | $455M | Buy |
7,252,746
+5,051,088
| +229% | +$404M | 0.42% | 45 |
|
|
2025
Q4 | $210M | Buy |
2,201,658
+2,167,794
| +6,401% | +$213M | 0.16% | 94 |
|
|
2025
Q3 | $3.31M | Sell |
33,864
-32,264
| -49% | -$3.34M | ﹤0.01% | 414 |
|
|
2025
Q2 | $7.1M | Sell |
66,128
-782,019
| -92% | -$79.1M | 0.01% | 348 |
|
|
2025
Q1 | $85.6M | Buy |
848,147
+84,585
| +11% | +$8.52M | 0.08% | 140 |
|
|
2024
Q4 | $68.2M | Sell |
763,562
-152,145
| -17% | -$13.4M | 0.06% | 155 |
|
|
2024
Q3 | $76.7M | Sell |
915,707
-478,376
| -34% | -$37.7M | 0.06% | 167 |
|
|
2024
Q2 | $107M | Sell |
1,394,083
-949,970
| -41% | -$69.5M | 0.09% | 116 |
|
|
2024
Q1 | $161M | Sell |
2,344,053
-213,986
| -8% | -$13.8M | 0.1% | 86 |
|
|
2023
Q4 | $148M | Buy |
2,558,039
+499,876
| +24% | +$26.7M | 0.21% | 90 |
|
|
2023
Q3 | $109M | Buy |
2,058,163
+97,230
| +5% | +$5.1M | 0.15% | 102 |
|
|
2023
Q2 | $106M | Sell |
1,960,933
-601,960
| -23% | -$31.4M | 0.13% | 100 |
|
|
2023
Q1 | $128M | Buy |
2,562,893
+855,502
| +50% | +$40.3M | 0.19% | 82 |
|
|
2022
Q4 | $79M | Sell |
1,707,391
-61
| -0% | -$2.64K | 0.13% | 138 |
|
|
2022
Q3 | $66.1M | Buy |
1,707,452
+13,532
| +0.8% | +$543K | 0.12% | 155 |
|
|
2022
Q2 | $63.1M | Buy |
1,693,920
+580,000
| +52% | +$23.6M | 0.11% | 162 |
|
|
2022
Q1 | $48.7M | Buy |
1,113,920
+192,065
| +21% | +$8.32M | 0.07% | 212 |
|
|
2021
Q4 | $39.9M | Buy |
921,855
+521,899
| +130% | +$21.9M | 0.07% | 192 |
|
|
2021
Q3 | $17.7M | Sell |
399,956
-31,359
| -7% | -$1.39M | 0.03% | 275 |
|
|
2021
Q2 | $18.6M | Sell |
431,315
-1,422
| -0.3% | -$59.8K | 0.04% | 257 |
|
|
2021
Q1 | $16.9M | Sell |
432,737
-247,983
| -36% | -$9.39M | 0.04% | 254 |
|
|
2020
Q4 | $24.3M | Buy |
680,720
+312,147
| +85% | +$11.3M | 0.06% | 225 |
|
|
2020
Q3 | $14M | Buy |
368,573
+285,973
| +346% | +$11M | 0.04% | 234 |
|
|
2020
Q2 | $2.88M | Sell |
82,600
-189,900
| -70% | -$6.84M | 0.01% | 365 |
|
|
2020
Q1 | $8.68M | Buy |
+272,500
| New | +$10.6M | 0.03% | 242 |
|
|
2019
Q3 | – | Sell |
-2,223,930
| Closed | -$93.4M | – | 674 |
|
|
2019
Q2 | $93.4M | Buy |
+2,223,930
| New | +$85.5M | 0.3% | 83 |
|
|
2019
Q1 | – | Sell |
-1,240,550
| Closed | -$43.8M | – | 633 |
|
|
2018
Q4 | $43.8M | Buy |
1,240,550
+808,650
| +187% | +$29.3M | 0.17% | 112 |
|
|
2018
Q3 | $16.6M | Buy |
+431,900
| New | +$15.1M | 0.05% | 194 |
|
|
2017
Q4 | – | Sell |
-8,008
| Closed | -$227K | – | 685 |
|
|
2017
Q3 | $227K | Buy |
+8,008
| New | +$221K | ﹤0.01% | 506 |
|
|
2016
Q4 | – | Sell |
-640
| Closed | -$15K | – | 748 |
|
|
2016
Q3 | $15K | Buy |
+640
| New | +$15.3K | ﹤0.01% | 585 |
|
Other funds holding BSX
1832 Asset Management's BSX Position: Q2 2026 in Review
1832 Asset Management reduced its Boston Scientific (BSX) stake by 37% in Q2 2026, selling an estimated $146M and leaving 4,556,876 shares worth $194M. The position accounts for 0.1% of the portfolio, ranked #110.
1832 Asset Management first reported a position in BSX in Q3 2016 and has held it in 31 quarters since. The position peaked at $455M in Q1 2026. 1,468 funds tracked by Wall St. Rank hold BSX as of Q2 2026.
- 1832 Asset Management held 4,556,876 shares of Boston Scientific worth $194M as of Q2 2026.
- 1832 Asset Management sold 2,695,870 Boston Scientific shares in Q2 2026, an estimated $146M.
- Boston Scientific made up 0.1% of 1832 Asset Management's portfolio in Q2 2026, its #110 holding.
- 1832 Asset Management first reported a position in Boston Scientific in Q3 2016 and has held it in 31 quarters since.
- 1832 Asset Management's Boston Scientific position peaked at $455M in Q1 2026.
- 1,468 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.
Based on 1832 Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.